Table of Content

Consumer Health in Austria
Euromonitor International
January 2023

List Of Contents And Tables

CONSUMER HEALTH IN AUSTRIA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 2 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2017-2022
Table 4 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 5 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 6 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 8 Distribution of Consumer Health by Format: % Value 2017-2022
Table 9 Distribution of Consumer Health by Format and Category: % Value 2022
Table 10 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return to hectic lifestyles stimulates demand for analgesics
Familiarity, large selections and residual COVID-19 effect boost adult aspirin
Bayer Austria leverages a strong offer and pays attention to key trends to satisfy consumers
PROSPECTS AND OPPORTUNITIES
Consumer lifestyles to stimulate the reach for analgesics
New product launches and switches to foster short-term growth opportunities
Stability anticipated in the competitive and distribution landscapes
CATEGORY DATA
Table 89 Sales of Analgesics by Category: Value 2017-2022
Table 90 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 91 NBO Company Shares of Analgesics: % Value 2018-2022
Table 92 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 93 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 94 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Shift back to out-of-home lifestyles increases incidence of and demand for cough, cold and allergy (hay fever) remedies
Wide variety and innovation stimulate interest in cough, cold and allergy remedies
More natural remedies remain popular alternatives
PROSPECTS AND OPPORTUNITIES
Rising incidence of infections and allergies to push retail sales
Environmental changes to stimulate the demand for products to cope with respiratory issues
Alternatives to undermine the demand for nasal decongestant drops, pharyngeal preparations and paediatric cough/cold remedies
CATEGORY DATA
Table 95 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 96 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Table 97 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
Table 98 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
Table 99 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
Table 100 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
DIGESTIVE REMEDIES IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Resumption of work norms and dining out increases potential for digestive problems
Digestive enzymes sees fastest growth as food intolerance grows
Bayer and Sanofi-Aventis vie for leadership through strong offer and wide distribution
PROSPECTS AND OPPORTUNITIES
Effective and fast-acting relief to drive retail sales
Tourism and tourism to push rebound in motion sickness remedies
Producers to invest in innovation to stimulate interest with pharmacies set to dominate sales
CATEGORY DATA
Table 12 Sales of Digestive Remedies by Category: Value 2017-2022
Table 13 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 14 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 15 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 16 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 17 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
DERMATOLOGICALS IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return to out-of-home lifestyles increases potential for skin complaints
Growing interest in personal appearance boosts hair loss treatments
Discontinuation of a leading brand deepens the decline in nappy (diaper) rash treatments
PROSPECTS AND OPPORTUNITIES
Environmental factors and closer contact with others to stimulate the need for dermatologicals
Low birth rate and kinder alternatives to hit nappy (diaper) rash treatments and paediatric dermatologicals
Bayer set to continue to leverage expertise and consumer trust to stay ahead of the field
CATEGORY DATA
Table 18 Sales of Dermatologicals by Category: Value 2017-2022
Table 19 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 20 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 21 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 22 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
Table 23 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 24 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
NRT SMOKING CESSATION AIDS IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
The demand for NRT smoking cessation aids slides amid a shrinking smoking population
Convenience and discretion maintain some interest in NRT patches and NRT inhalators
The competitive landscape remains a duopoly
PROSPECTS AND OPPORTUNITIES
Health and wellness to remain a key driver for NRT smoking cessation aids
Little dynamism expected in terms of new product development
NRT lozenges and NRT patches to gain popularity as alternatives to NRT gum
CATEGORY INDICATORS
Table 25 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 26 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 27 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 28 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 29 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 30 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 31 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
SLEEP AIDS IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return to more hectic lifestyles fosters residual call for sleep aids
Turn to healthy living alternatives challenges OTC sleep aids
Natural and herbal components influence consumer brand choices
PROSPECTS AND OPPORTUNITIES
Sleep aids to remain in demand as everyday stresses replace pandemic concerns
Consumers to seek natural ingredients and products and practical solutions
Concerns over side effects to continue to favour physical pharmacies
CATEGORY DATA
Table 32 Sales of Sleep Aids: Value 2017-2022
Table 33 Sales of Sleep Aids: % Value Growth 2017-2022
Table 34 NBO Company Shares of Sleep Aids: % Value 2018-2022
Table 35 LBN Brand Shares of Sleep Aids: % Value 2019-2022
Table 36 Forecast Sales of Sleep Aids: Value 2022-2027
Table 37 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
EYE CARE IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return to pre-pandemic lifestyles revives eye care
Ageing population and the digital boom hasten standard eye care?s recovery
Bausch & Lomb discontinues Olixia but hangs on the leading position
PROSPECTS AND OPPORTUNITIES
Lifestyles and climate to heavily influence demand
Digitalisation offers growth opportunities in eye care
Positioning in physical pharmacies remains a key competitive tool
CATEGORY DATA
Table 38 Sales of Eye Care by Category: Value 2017-2022
Table 39 Sales of Eye Care by Category: % Value Growth 2017-2022
Table 40 NBO Company Shares of Eye Care: % Value 2018-2022
Table 41 LBN Brand Shares of Eye Care: % Value 2019-2022
Table 42 Forecast Sales of Eye Care by Category: Value 2022-2027
Table 43 Forecast Sales of Eye Care by Category: % Value Growth 2022-2027
WOUND CARE IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Earlier stockpiling limits the room for growth in 2022
New product launches continue to add dynamism to wound care
Drugstores remain top-of-mind due to a wide offer, competitive prices and convenient access
PROSPECTS AND OPPORTUNITIES
Retail volume and value growth anticipated in line with more active lifestyles
Innovation and new launches to remain growth drivers
The competitive and distribution landscapes are set to be stable
CATEGORY DATA
Table 44 Sales of Wound Care by Category: Value 2017-2022
Table 45 Sales of Wound Care by Category: % Value Growth 2017-2022
Table 46 NBO Company Shares of Wound Care: % Value 2018-2022
Table 47 LBN Brand Shares of Wound Care: % Value 2019-2022
Table 48 Forecast Sales of Wound Care by Category: Value 2022-2027
Table 49 Forecast Sales of Wound Care by Category: % Value Growth 2022-2027
VITAMINS IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Slowdown in sales development following pandemic spikes
Growing appreciation of versatile vitamin E
Stable, but competitive landscape
PROSPECTS AND OPPORTUNITIES
Lack of pandemic push and level of saturation to hinder sales development
Multivitamins and vitamin E to benefit from convenience and versatility
New product development in order to offset growing competition from private label
CATEGORY DATA
Table 50 Sales of Vitamins by Category: Value 2017-2022
Table 51 Sales of Vitamins by Category: % Value Growth 2017-2022
Table 52 Sales of Multivitamins by Positioning: % Value 2017-2022
Table 53 NBO Company Shares of Vitamins: % Value 2018-2022
Table 54 LBN Brand Shares of Vitamins: % Value 2019-2022
Table 55 Forecast Sales of Vitamins by Category: Value 2022-2027
Table 56 Forecast Sales of Vitamins by Category: % Value Growth 2022-2027
DIETARY SUPPLEMENTS IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Prevention over cure and self-management of health trends push consumers towards dietary supplements
Combination dietary supplements benefits from the demand for convenient and easy-to-use products
Richard Bittner continues to lead through its strong Abtei range
PROSPECTS AND OPPORTUNITIES
Dietary supplements to receive a boost from the ageing population trend
Newer and more innovative products to be welcomed by consumers
E-commerce to continue to ride the convenience wave, while pharmacies remains a highly trusted channel
CATEGORY DATA
Table 57 Sales of Dietary Supplements by Category: Value 2017-2022
Table 58 Sales of Dietary Supplements by Category: % Value Growth 2017-2022
Table 59 Sales of Dietary Supplements by Positioning: % Value 2017-2022
Table 60 NBO Company Shares of Dietary Supplements: % Value 2018-2022
Table 61 LBN Brand Shares of Dietary Supplements: % Value 2019-2022
Table 62 Forecast Sales of Dietary Supplements by Category: Value 2022-2027
Table 63 Forecast Sales of Dietary Supplements by Category: % Value Growth 2022-2027
WEIGHT MANAGEMENT AND WELLBEING IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Demand grows as consumers look for ways to shed weight gained during the pandemic
Convenience aspect boosts meal replacement
Herbalife leverages strong weight management and wellbeing programmes to stay well ahead of the field
PROSPECTS AND OPPORTUNITIES
Economic concerns to maintain a focus on price
Attention to personal appearance to stimulate interest in weight management and wellbeing
Direct selling development to spur e-commerce
CATEGORY DATA
Table 64 Sales of Weight Management and Wellbeing by Category: Value 2017-2022
Table 65 Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022
Table 66 NBO Company Shares of Weight Management and Wellbeing: % Value 2018-2022
Table 67 LBN Brand Shares of Weight Management and Wellbeing: % Value 2019-2022
Table 68 Forecast Sales of Weight Management and Wellbeing by Category: Value 2022-2027
Table 69 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2022-2027
SPORTS NUTRITION IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return to pre-pandemic norms spurs full recovery in demand
New options and growing selections in retail channels stimulate awareness
Versatility and wider distribution boost sports protein powder
PROSPECTS AND OPPORTUNITIES
Social media use to enhance positioning of sports nutrition
Growing selections in a variety of channels to increase visibility and create interest
Stronger, more diverse offer to intensify the competitive landscape
CATEGORY DATA
Table 70 Sales of Sports Nutrition by Category: Value 2017-2022
Table 71 Sales of Sports Nutrition by Category: % Value Growth 2017-2022
Table 72 NBO Company Shares of Sports Nutrition: % Value 2018-2022
Table 73 LBN Brand Shares of Sports Nutrition: % Value 2019-2022
Table 74 Forecast Sales of Sports Nutrition by Category: Value 2022-2027
Table 75 Forecast Sales of Sports Nutrition by Category: % Value Growth 2022-2027
HERBAL/TRADITIONAL PRODUCTS IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Robust demand although supply issues and external competition limit growth potential
Slow return to experimentation with herbal/traditional products
Versatility and trust underpin the leadership of Ricola and Wick
PROSPECTS AND OPPORTUNITIES
Prevention over cure trend to provide push-pull effects
Herbal/traditional sleep aids to benefit from the effects of hectic lifestyles
Growing space for smaller, independent and niche players
CATEGORY DATA
Table 76 Sales of Herbal/Traditional Products by Category: Value 2017-2022
Table 77 Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022
Table 78 NBO Company Shares of Herbal/Traditional Products: % Value 2018-2022
Table 79 LBN Brand Shares of Herbal/Traditional Products: % Value 2019-2022
Table 80 Forecast Sales of Herbal/Traditional Products by Category: Value 2022-2027
Table 81 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2022-2027
PAEDIATRIC CONSUMER HEALTH IN AUSTRIA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Discontinuations and supply issues see strong decreases in demand for nappy (diaper) rash treatments and paediatric diarrhoeal remedies
Reluctance to use standard medicines on children limits growth potential
Parents continue to look to vitamins and dietary supplements to provide children with extra protection
PROSPECTS AND OPPORTUNITIES
Downward trajectory of the 0-4-year-old population to hinder sales development of paediatric consumer health
Apomedica and Bayer Austria set to continue to leverage brand loyalty and trust to stay ahead of the field
Personal touch and trust favours pharmacies when purchasing paediatric products
CATEGORY DATA
Table 82 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 83 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 84 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 85 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
Table 86 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
Table 87 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 88 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027